Home The Word Brain	My Amedeo FAQ Privacy About
	As of October 2023, Amedeo had 12,263 active subscribers

Malignant Melanoma

Free Subscription Articles published in J Immunol Retrieve available abstracts of 20 articles: HTML format

Single Articles

July 2023
1. THOMPSON B, Strange A, Amato CM, Hester-McCullough J, et al
   CD4 Phenotypes Are Associated with Reduced Expansion of Tumor-Infiltrating Lymphocytes in Melanoma Patients Treated with Adoptive Cell Therapy.
   J Immunol. 2023 Jul 19:ji2300250. doi: 10.4049/jimmunol.2300250.
   PubMed     Abstract available
   
   
   March 2023
2. ALAM MM, Gower T, Jiang M, Oppenheim JJ, et al
   A Therapeutic Vaccine in Combination with Cyclic GMP-AMP Cures More Differentiated Melanomas in Mice.
   J Immunol. 2023 Mar 22:ji2200371. doi: 10.4049/jimmunol.2200371.
   PubMed     Abstract available
   
   
   December 2022
3. MIYAMOTO M, Himeda T, Ishihara K, Okuwa T, et al
   Theilovirus 3C Protease Cleaves the C-Terminal Domain of the Innate Immune RNA Sensor, Melanoma Differentiation-Associated Gene 5, and Impairs Double-Stranded RNA-Mediated IFN Response.
   J Immunol. 2022 Dec 14:ji2200565. doi: 10.4049/jimmunol.2200565.
   PubMed     Abstract available
   
   
   September 2022
4. LI P, Chen X, Ping Y, Qin G, et al
   Clinical Correlation of Function and TCR vbeta Diversity of MAGE-C2-Specific CD8(+) T Cell Response in Esophageal Cancer.
   J Immunol. 2022;209:1039-1047.
   PubMed     Abstract available
   
   
   July 2022
5. PAN W, Scherlinger M, Yoshida N, Tsokos MG, et al
   PPP2R2D Suppresses Effector T Cell Exhaustion and Regulatory T Cell Expansion and Inhibits Tumor Growth in Melanoma.
   J Immunol. 2022 Jul 13. pii: jimmunol.2200041. doi: 10.4049/jimmunol.2200041.
   PubMed     Abstract available
   
   
   
6. VOILLET V, Berger TR, McKenna KM, Paulson KG, et al
   An In Vivo Model of Human Macrophages in Metastatic Melanoma.
   J Immunol. 2022 Jul 11. pii: jimmunol.2101109. doi: 10.4049/jimmunol.2101109.
   PubMed     Abstract available
   
   
   April 2022
7. BORDEN ES, Ghafoor S, Buetow KH, LaFleur BJ, et al
   NeoScore Integrates Characteristics of the Neoantigen:MHC Class I Interaction and Expression to Accurately Prioritize Immunogenic Neoantigens.
   J Immunol. 2022;208:1813-1827.
   PubMed     Abstract available
   
   
   January 2022
8. SILK JD, Abbott RJM, Adams KJ, Bennett AD, et al
   Engineering Cancer Antigen-Specific T Cells to Overcome the Immunosuppressive Effects of TGF-beta.
   J Immunol. 2022;208:169-180.
   PubMed     Abstract available
   
   
   November 2021
9. HINKLE L, Liu Y, Meng C, Chen Z, et al
   The Sympathetic Nervous System Modulates Cancer Vaccine Activity through Monocyte-Derived Cells.
   J Immunol. 2021 Nov 12. pii: jimmunol.2100719. doi: 10.4049/jimmunol.2100719.
   PubMed     Abstract available
   
   
   September 2021
10. LI Z, Gao Y, He C, Wei H, et al
    Purinergic Receptor P2Y6 Is a Negative Regulator of NK Cell Maturation and Function.
    J Immunol. 2021;207:1555-1565.
    PubMed     Abstract available
    
    
    
11. OROZCO RC, Marquardt K, Mowen K, Sherman LA, et al
    Proautoimmune Allele of Tyrosine Phosphatase, PTPN22, Enhances Tumor Immunity.
    J Immunol. 2021;207:1662-1671.
    PubMed     Abstract available
    
    
    
12. ISLAM A, Pishesha N, Harmand TJ, Heston H, et al
    Converting an Anti-Mouse CD4 Monoclonal Antibody into an scFv Positron Emission Tomography Imaging Agent for Longitudinal Monitoring of CD4(+) T Cells.
    J Immunol. 2021;207:1468-1477.
    PubMed     Abstract available
    
    
    July 2021
13. CARLSON PM, Mohan M, Patel RB, Birstler J, et al
    Optimizing Flow Cytometric Analysis of Immune Cells in Samples Requiring Cryopreservation from Tumor-Bearing Mice.
    J Immunol. 2021;207:720-734.
    PubMed     Abstract available
    
    
    
14. BANERJEE A, Li D, Guo Y, Mahgoub B, et al
    Retargeting IL-2 Signaling to NKG2D-Expressing Tumor-Infiltrating Leukocytes Improves Adoptive Transfer Immunotherapy.
    J Immunol. 2021;207:333-343.
    PubMed     Abstract available
    
    
    April 2021
15. CHEN CW, Bennion KB, Swift DA, Morrow KN, et al
    Tumor-Specific T Cells Exacerbate Mortality and Immune Dysregulation during Sepsis.
    J Immunol. 2021 Apr 28. pii: jimmunol.2000865. doi: 10.4049/jimmunol.2000865.
    PubMed     Abstract available
    
    
    March 2021
16. SINGH S, Xiao Z, Bavisi K, Roszik J, et al
    IL-1alpha Mediates Innate and Acquired Resistance to Immunotherapy in Melanoma.
    J Immunol. 2021 Mar 15. pii: jimmunol.2000523. doi: 10.4049/jimmunol.2000523.
    PubMed     Abstract available
    
    
    January 2021
17. O'CONNELL P, Hyslop S, Blake MK, Godbehere S, et al
    SLAMF7 Signaling Reprograms T Cells toward Exhaustion in the Tumor Microenvironment.
    J Immunol. 2021;206:193-205.
    PubMed     Abstract available
    
    
    October 2020
18. OBA T, Hoki T, Yamauchi T, Keler T, et al
    A Critical Role of CD40 and CD70 Signaling in Conventional Type 1 Dendritic Cells in Expansion and Antitumor Efficacy of Adoptively Transferred Tumor-Specific T Cells.
    J Immunol. 2020;205:1867-1877.
    PubMed     Abstract available
    
    
    July 2020
19. TUCKER CG, Mitchell JS, Martinov T, Burbach BJ, et al
    Adoptive T Cell Therapy with IL-12-Preconditioned Low-Avidity T Cells Prevents Exhaustion and Results in Enhanced T Cell Activation, Enhanced Tumor Clearance, and Decreased Risk for Autoimmunity.
    J Immunol. 2020 Jul 31. pii: jimmunol.2000007. doi: 10.4049/jimmunol.2000007.
    PubMed     Abstract available
    
    
    April 2020
20. WILSKI NA, Stotesbury C, Del Casale C, Montoya B, et al
    STING Sensing of Murine Cytomegalovirus Alters the Tumor Microenvironment to Promote Antitumor Immunity.
    J Immunol. 2020 Apr 13. pii: jimmunol.1901136. doi: 10.4049/jimmunol.1901136.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Malignant Melanoma is free of charge.